久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • MEI Announces FDA Clearance of IND Application for Voruciclib americanpharmaceuticalreview
    January 09, 2018
    MEI Pharma announced the FDA has cleared the company's Investigational New Drug Application for voruciclib, an orally available Cyclin Dependent Kinase 9 (CDK9) inhibitor, for patients with relapsed/refractory B-cell malignancies.
PharmaSources Customer Service